We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02437253
Brief Title: Effects of Adalimumab in Mucopolysaccharidosis Types I, II and VI

First Submitted : May 5, 2015
First Submitted that Met QC Criteria : May 5, 2015
First Posted : May 7, 2015 (Estimate)

Results First Submitted : May 3, 2017
Results First Submitted that Met QC Criteria : August 16, 2017
Results First Posted : September 15, 2017

Last Update Submitted that Met QC Criteria : August 16, 2017
Last Update Posted : September 15, 2017